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Dysphagia, often associated with conditions such as stroke, Parkinson’s disease, multiple sclerosis, 
and dementia, causes patients to have difficulty with swallowing food and/or liquids. These patients 
require their fluids to be thickened using gum-based thickening powders in order to facilitate safe 
swallowing. These thickened fluids are also used as a vehicle for delivery of crushed medicines. Our 
in vitro measurements suggest that thickened fluids can delay and reduce the dissolution of a 
number of medications. This study was conducted to assess the impact of the use of thickened fluids 
on the clinical pharmacokinetics of oral paracetamol.  
 
METHODS 
20 Healthy volunteers were administered a single oral dose (1g) of paracetamol as either whole 
tablets, crushed with water, crushed with semi-solid jam, or crushed with thickened fluid according 
to a randomised, crossover design. Saliva samples were collected periodically over 8 hr and 
paracetamol concentration analysed by HPLC-UV. Non-compartmental pharmacokinetic analysis was 
conducted using Winnonlin®. 
 
RESULTS 
The mean peak concentration (Cmax) of paracetamol ranged between 5.62 – 8.00 μg/mL. 
Comparison between the crushed paracetamol with thickened water (Level 900) and other 
treatment options (whole, crushed with water, and crushed with jam) showed there was a 
significant difference in Cmax at 90% CI (p < 0.05). Also, whole tablet had a significant difference in 
Cmax between crushed with water and crushed with jam. There was no significant difference in AUC 
irrespective of the treatment. 
 
DISCUSSION 
The use of thickened water resulted in alteration in the absorption kinetics of paracetamol. Given 
this interaction, co-administration with thickened fluids may have important clinical implications for 
medications with a narrow therapeutic index.
